This is the authors' abstract. We don't add key points for this paper.
TBI occurs frequently in the military and civilian settings with limited methods to diagnose and prognosticate outcomes. We highlighted several promising biomarkers for these purposes including S100B, UCH-L1, NFL, GFAP, and tau proteins. S100B and UCH-L1 appear to have the strongest data to date, but further research is necessary. The robust data that explain the optimal timing and, more importantly, trending of these biomarker measurements are necessary before widespread application.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kocik et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: